Impact of molecular biology on Pseudomonas aeruginosa immunization
- 1 February 1988
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 11, 96-102
- https://doi.org/10.1016/0195-6701(88)90173-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy of intravenous immune globulin for treatment of experimental pseudomonas aeruginosa pneumoniaJournal of Critical Care, 1986
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPIDThe Lancet, 1985
- The Clinical Challenge of Infections Due to Pseudomonas aeruginosaClinical Infectious Diseases, 1984
- Bacteremic Nosocomial PneumoniaAmerican Review of Respiratory Disease, 1984
- Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosaThe American Journal of Medicine, 1984
- Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial TherapyClinical Infectious Diseases, 1983
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Lipopolysaccharide Pseudomonas Vaccine: Efficacy Against Pulmonary Infection with Pseudomonas aeruginosaThe Journal of Infectious Diseases, 1979
- Epidemiology of Nosocomial Infections Due to Gram-Negative Bacilli: Aspects Relevant to Development and Use of VaccinesThe Journal of Infectious Diseases, 1977
- Pneumonia in an intensive care unit. A 30-month experienceArchives of internal medicine (1960), 1974